TAFI gene polymorphisms in patients with cerebral venous thrombosis
Küçük Resim Yok
Tarih
2013
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Springer Heidelberg
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Gene polymorphisms of thrombin activatable fibrinolysis inhibition (TAFI) factor have been investigated in various studies in terms of etiology (recurrence) and treatment (fibrinolytic effect) of thrombus formation. Cerebral venous thrombosis (CVT) is a life-threatening disease observed in young persons. Fifty-nine patients with CVT and 100 healthy control subjects were enrolled in the case/control study. The association between TAFI gene polymorphisms -438G > A, +505A > G and +1040C > T and cerebral venous thrombosis was investigated. It was found that frequencies of polymorphic genotype and allele were not different in patients than in control group and that they were not significant for cerebral venous thrombosis.
Açıklama
Anahtar Kelimeler
Tafi, Cerebral Venous Thrombosis, 438g > A, 505a > G, 1040c > T, Sinus Thrombosis
Kaynak
Acta Neurologica Belgica
WoS Q Değeri
Q4
Scopus Q Değeri
Q2
Cilt
113
Sayı
3
